Miho Ota1, Masanori Ishikawa2, Noriko Sato3, Mitsutoshi Okazaki2, Norihide Maikusa4, Hiroaki Hori5, Kotaro Hattori5, Toshiya Teraishi5, Kimiteru Ito3, Hiroshi Kunugi5. 1. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1, Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan. Electronic address: ota@ncnp.go.jp. 2. Department of Psychiatry, National Center of Neurology and Psychiatry, 4-1-1, Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan. 3. Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1, Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan. 4. Department of Imaging Neuroinformatics, Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, 4-1-1, Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan. 5. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1, Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan.
Abstract
UNLABELLED: Arterial spin labeling (ASL) magnetic resonance imaging (MRI) is a novel noninvasive technique that can measure regional cerebral blood flow (rCBF). To our knowledge, few studies have examined rCBF in patients with schizophrenia by ASL-MRI. Here we used pseudo-continuous ASL (pCASL) to examine the structural and functional imaging data in schizophrenic patients, taking the regional cerebral gray matter volume into account. The subjects were 36 patients with schizophrenia and 42 healthy volunteers who underwent 3-tesla MRI, diffusion tensor imaging (DTI), and pCASL. We evaluated the gray matter volume imaging, DTI, and pCASL imaging data in a voxel-by-voxel statistical analysis. The schizophrenia patients showed reduced rCBF in the left prefrontal and bilateral occipital cortices compared to the healthy volunteers. There was a significant reduction of gray matter volume in the left inferior frontal cortex in the schizophrenia patients. With respect to the fractional anisotropy (FA) values in the DTI, there were significant FA reductions in the left superior temporal, left external capsule, and left inferior prefrontal regions in the patients compared to the controls. CONCLUSION: Our pCASL study with partial volume effect correction together with volumetry and DTI data demonstrated hypoactivity in the left prefrontal area beyond structural abnormalities in schizophrenia patients. There were also hypofunction areas in bilateral occipital cortices, although structural abnormalities were not apparent.
UNLABELLED: Arterial spin labeling (ASL) magnetic resonance imaging (MRI) is a novel noninvasive technique that can measure regional cerebral blood flow (rCBF). To our knowledge, few studies have examined rCBF in patients with schizophrenia by ASL-MRI. Here we used pseudo-continuous ASL (pCASL) to examine the structural and functional imaging data in schizophrenicpatients, taking the regional cerebral gray matter volume into account. The subjects were 36 patients with schizophrenia and 42 healthy volunteers who underwent 3-tesla MRI, diffusion tensor imaging (DTI), and pCASL. We evaluated the gray matter volume imaging, DTI, and pCASL imaging data in a voxel-by-voxel statistical analysis. The schizophreniapatients showed reduced rCBF in the left prefrontal and bilateral occipital cortices compared to the healthy volunteers. There was a significant reduction of gray matter volume in the left inferior frontal cortex in the schizophreniapatients. With respect to the fractional anisotropy (FA) values in the DTI, there were significant FA reductions in the left superior temporal, left external capsule, and left inferior prefrontal regions in the patients compared to the controls. CONCLUSION: Our pCASL study with partial volume effect correction together with volumetry and DTI data demonstrated hypoactivity in the left prefrontal area beyond structural abnormalities in schizophreniapatients. There were also hypofunction areas in bilateral occipital cortices, although structural abnormalities were not apparent.
Authors: Sergey Shcherbinin; Orla Doyle; Fernando O Zelaya; Sara de Simoni; Mitul A Mehta; Adam J Schwarz Journal: Psychopharmacology (Berl) Date: 2015-07-31 Impact factor: 4.530
Authors: Jun Hua; Nicholas I S Blair; Adrian Paez; Ann Choe; Anita D Barber; Allison Brandt; Issel Anne L Lim; Feng Xu; Vidyulata Kamath; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis Journal: Schizophr Res Date: 2018-11-06 Impact factor: 4.939
Authors: Karoline Schneider; Lars Michels; Matthias N Hartmann-Riemer; Achim Burrer; Philippe N Tobler; Philipp Stämpfli; Matthias Kirschner; Erich Seifritz; Stefan Kaiser Journal: J Psychiatry Neurosci Date: 2019-03-01 Impact factor: 6.186
Authors: Mustapha Bouhrara; Diana Y Lee; Abinand C Rejimon; Christopher M Bergeron; Richard G Spencer Journal: J Neurosci Methods Date: 2018-08-18 Impact factor: 2.390
Authors: Christian S Legind; Brian V Broberg; Rachel Brouwer; René C W Mandl; Bjørn H Ebdrup; Simon J Anhøj; Maria H Jensen; Rikke Hilker; Birgitte Fagerlund; Hilleke E Hulshoff Pol; Birte Y Glenthøj; Egill Rostrup Journal: Schizophr Bull Date: 2019-10-24 Impact factor: 9.306
Authors: Jun Hua; Allison S Brandt; SeungWook Lee; Nicholas I S Blair; Yuankui Wu; Su Lui; Jaymin Patel; Andreia V Faria; Issel Anne L Lim; Paul G Unschuld; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis Journal: Schizophr Bull Date: 2017-05-01 Impact factor: 9.306
Authors: S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: Neuropsychopharmacology Date: 2016-08-26 Impact factor: 7.853